Banghulot, Baby Boy .
HRN: 21-63-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/21/2022
07/28/2022
IV
50 Mg
Q24 Hrs
MSAF Thinly PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes